• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Transl Med . . A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae

tetano

Editor, Senior Moderator
Sci Transl Med


. 2022 Nov 16;14(671):eabo5795.
doi: 10.1126/scitranslmed.abo5795. Epub 2022 Nov 16.
A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae


Peter M George[SUP] 1 2 [/SUP], Anna Reed[SUP] 1 2 [/SUP], Sujal R Desai[SUP] 1 2 [/SUP], Anand Devaraj[SUP] 1 2 [/SUP], Tasnim Shahridan Faiez[SUP] 3 [/SUP], Sarah Laverty[SUP] 4 [/SUP], Amama Kanwal[SUP] 5 [/SUP], Camille Esneau[SUP] 5 [/SUP], Michael K C Liu[SUP] 4 [/SUP], Faisal Kamal[SUP] 6 [/SUP], William D-C Man[SUP] 1 2 7 [/SUP], Sundeep Kaul[SUP] 1 [/SUP], Suveer Singh[SUP] 1 [/SUP], Georgia Lamb[SUP] 1 [/SUP], Fatima K Faizi[SUP] 3 [/SUP], Michael Schuliga[SUP] 5 [/SUP], Jane Read[SUP] 5 [/SUP], Thomas Burgoyne[SUP] 1 8 [/SUP], Andreia L Pinto[SUP] 1 [/SUP], Jake Micallef[SUP] 9 [/SUP], Emilie Bauwens[SUP] 9 [/SUP], Julie Candiracci[SUP] 9 [/SUP], Mhammed Bougoussa[SUP] 9 [/SUP], Marielle Herzog[SUP] 9 [/SUP], Lavanya Raman[SUP] 2 [/SUP], Blerina Ahmetaj-Shala[SUP] 2 [/SUP], Stuart Turville[SUP] 10 [/SUP], Anupriya Aggarwal[SUP] 10 [/SUP], Hugo A Farne[SUP] 2 10 11 [/SUP], Alessia Dalla Pria[SUP] 4 12 [/SUP], Andrew D Aswani[SUP] 13 14 [/SUP], Francesca Patella[SUP] 15 [/SUP], Weronika E Borek[SUP] 15 [/SUP], Jane A Mitchell[SUP] 2 [/SUP], Nathan W Bartlett[SUP] 5 [/SUP], Arran Dokal[SUP] 15 [/SUP], Xiao-Ning Xu[SUP] 4 [/SUP], Peter Kelleher[SUP] 1 12 16 17 [/SUP], Anand Shah[SUP] 1 18 [/SUP], Aran Singanayagam[SUP] 3 [/SUP]



Affiliations

Abstract

Interstitial lung disease and associated fibrosis occur in a proportion of individuals who have recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection through unknown mechanisms. We studied individuals with severe coronavirus disease 2019 (COVID-19) after recovery from acute illness. Individuals with evidence of interstitial lung changes at 3 to 6 months after recovery had an up-regulated neutrophil-associated immune signature including increased chemokines, proteases, and markers of neutrophil extracellular traps that were detectable in the blood. Similar pathways were enriched in the upper airway with a concomitant increase in antiviral type I interferon signaling. Interaction analysis of the peripheral phosphoproteome identified enriched kinases critical for neutrophil inflammatory pathways. Evaluation of these individuals at 12 months after recovery indicated that a subset of the individuals had not yet achieved full normalization of radiological and functional changes. These data provide insight into mechanisms driving development of pulmonary sequelae during and after COVID-19 and provide a rational basis for development of targeted approaches to prevent long-term complications.
 
Back
Top Bottom